Prem S. Shah - Nov 30, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Group President
Signature
/s/ Prem S. Shah
Stock symbol
CVS
Transactions as of
Nov 30, 2024
Transactions value $
$53,596,968
Form type
4
Date filed
12/3/2024, 05:14 PM
Previous filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 42.3K Nov 30, 2024 Direct
holding CVS Common Stock (Restricted) 37.1K Nov 30, 2024 Direct
holding CVS ESOP Common Stock 4.97K Nov 30, 2024 Direct
holding CVS Stock Unit (deferred) 3.47K Nov 30, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Premium Stock Option Award $53.6M +746K $71.82 746K Nov 30, 2024 Common Stock 746K $71.82 Direct F12
holding CVS Phantom Stock Credits 39.6K Nov 30, 2024 Common Stock 39.6K $1.00 Direct F2, F3
holding CVS Stock Option 846 Nov 30, 2024 Common Stock 846 $62.21 Direct F4
holding CVS Stock Option 9.47K Nov 30, 2024 Common Stock 9.47K $54.19 Direct F5
holding CVS Stock Option 28.6K Nov 30, 2024 Common Stock 28.6K $58.34 Direct F6
holding CVS Stock Option 26.6K Nov 30, 2024 Common Stock 26.6K $75.24 Direct F7
holding CVS Stock Option 28.7K Nov 30, 2024 Common Stock 28.7K $74.30 Direct F8
holding CVS Stock Option 41.6K Nov 30, 2024 Common Stock 41.6K $101.09 Direct F9
holding CVS Stock Option 89.1K Nov 30, 2024 Common Stock 89.1K $74.31 Direct F10
holding CVS Stock Option 62.7K Nov 30, 2024 Common Stock 62.7K $79.56 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F5 Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
F6 Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F7 Option became exercisable in three equal installments, commencing on 8/31/2021.
F8 Option became exercisable in three equal installments commencing 04/01/2022.
F9 Option became exercisable in four equal installments, commencing 4/1/2023.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2024.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2025.
F12 Option becomes exercisable in three equal annual installments, commencing 11/30/2025.